Category Archives: PRESS RELEASES

SLN124 granted Orphan Drug Designation by EMA for the treatment of β-Thalassemia

SLN124 granted Orphan Drug Designation by EMA for the treatment of β-Thalassemia January 15, 2019 LONDON, Silence Therapeutics, PLC (LON: SLN) (“Silence” or “the Company”) a leader in the discovery, development and delivery of novel RNA therapeutics for the treatment… Read More

CNH Industrial announces senior leadership change

London, January 15, 2019 CNH Industrial N.V. (NYSE: CNHI / MI: CNHI) announces that Pierre Lahutte is stepping down, with immediate effect, as Brand President of IVECO. The Company thanks Pierre for his leadership of IVECO for the past four… Read More

Radware Report Shows That Respondants Claim Average Cost of Cyberattack Now Exceeds $1 Million

Operational/Productivity Loss (54%) and Negative Customer Experience (43%) are Identified as the Primary Impacts of Cyberattacks MAHWAH, N.J., Jan. 15, 2019 (GLOBE NEWSWIRE) — Radware® (NASDAQ: RDWR), a leading provider of cybersecurity and application delivery solutions, today announced it has… Read More

DoubleVerify Acquires Leiki – Leading Contextual Intelligence Platform

Acquisition Fortifies DV Brand Safety Solutions Globally NEW YORK, Jan. 14, 2019 (GLOBE NEWSWIRE) — DoubleVerify, the leading independent provider of marketing measurement software and analytics, today announced that it has acquired Leiki, Ltd., a leading contextual intelligence and content… Read More

PSAV® and The Freeman Company Announce Purchase Agreement for PSAV to Acquire Encore Event Technologies

SCHILLER PARK, IL, and DALLAS,TX, Jan. 14, 2019 (GLOBE NEWSWIRE) — PSAV, a global leader in event experiences, and The Freeman Company, jointly announced today that the companies have entered into a purchase agreement for PSAV to acquire Encore Event… Read More

TRIO Enrolls First Patient Into PHASE III NATALEE Clinical Trial

Timely Enrollment Signifies Milestone in TRIO EDMONTON, Alberta, Jan. 14, 2019 (GLOBE NEWSWIRE) — Translational Research In Oncology (TRIO), in collaboration with Novartis and under the direction of Dennis Slamon, MD, PhD, TRIO Chairman/Executive Director and Director of Clinical Translational… Read More

Alberta set to welcome next generation of AI experts

EDMONTON, Alberta, Jan. 14, 2019 (GLOBE NEWSWIRE) — The Alberta Machine Intelligence Institute (Amii) has launched applications for the 11thannual Deep Learning and Reinforcement Learning Summer School, happening July 24 – August 2, 2019 at the University of Alberta in … Read More